Invention Grant
- Patent Title: HCV-derived polypeptides and uses thereof
- Patent Title (中): HCV衍生的多肽及其用途
-
Application No.: US13256786Application Date: 2010-03-17
-
Publication No.: US08735346B2Publication Date: 2014-05-27
- Inventor: Thomas Krey , Felix A. Rey , Carlos Massayuki Kikuti , Laurence Damier-Piolle
- Applicant: Thomas Krey , Felix A. Rey , Carlos Massayuki Kikuti , Laurence Damier-Piolle
- Applicant Address: FR Paris
- Assignee: Institut Pasteur
- Current Assignee: Institut Pasteur
- Current Assignee Address: FR Paris
- Agency: Foley & Lardner LLP
- Priority: CA2658714 20090317
- International Application: PCT/IB2010/051158 WO 20100317
- International Announcement: WO2010/106509 WO 20100923
- Main IPC: A61K38/16
- IPC: A61K38/16 ; C07K14/18 ; A61P31/14
Abstract:
The present invention relates to Hepatitis C virus (HCV)-derived polypeptides and nucleic acid molecules encoding same which advantageously comprises a cd81-binding region. In this connection, the present invention specifically relates to the use of the polypeptides or nucleic acid molecules in compositions and methods for the prevention, the treatment and the diagnosis of HCV infections.
Public/Granted literature
- US20120088718A1 HCV-DERIVED POLYPEPTIDES AND USES THEREOF Public/Granted day:2012-04-12
Information query
IPC分类:
